ArriVent BioPharma Inc — Quarterly Financial Statistics (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -16.15 M-68.01 M-26.12 M-35.8 M-30.66 M -160.59 M Cash from investing activities —36.82 M13.91 M-50.76 M-71.2 M -71.23 M Cash from financing activities 55 K6.76 M75.11 M86.47 M34.73 M 203.06 M Free cash flow -16.15 M-68.01 M-26.12 M-35.8 M-30.66 M -160.59 M

Haberler

Are You Looking for a Top Momentum Pick? Why ArriVent BioPharma, Inc. (AVBP) is a Great Choice

Are Medical Stocks Lagging AstraZeneca (AZN) This Year?

Arrivent Biopharma hissesi 27,25 dolarda 52 haftalık zirve yaptı

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

ArriVent BioPharma: Phase 3 Delay May Signal Stronger Outcomes For Firmonertinib (NASDAQ:AVBP)

BTIG, ArriVent hissesi için alım tavsiyesi verdi

BTIG initiates ArriVent stock coverage with buy rating on oncology pipeline

Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Cantor Fitzgerald, ArriVent hissesi için Ağırlık Artırma notunu yineledi

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer, ArriVent BioPharma hissesi için Outperform notunu yineledi